Amarin’s Triglyceride-Lowering Drug Gets Second FDA Nod to Tackle Cardiovascular Disease
A treatment developed by the Irish company Amarin has become the first FDA-approved drug to…
A treatment developed by the Irish company Amarin has become the first FDA-approved drug to…
4TEEN4 Pharmaceuticals has raised a Series A round of €6.9M to fuel the development of…
Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest…
A research group in Italy has reduced cardiovascular disease in mice by expressing an anti-aging…
A food supplement made from bacteria, developed by a Belgian research group, has improved symptoms…
A study run by the Finnish diagnostics biotech Zora Biosciences has found two biomarkers that…
Owlstone Medical and the Swiss biotech Actelion have teamed up to co-develop a breathalyzer that…
A group of scientists in Israel is the first to 3D print a vascularized heart…
The Swiss company NovaGo has raised €8.8M (CHF 10M) in Series A funding to develop…
Novo Nordisk and the Dutch company Staten Biotechnology will partner to develop a treatment to…
The French company Quantum Genomics is developing a first-in-class drug that targets proteins in the…
Omeicos Therapeutics has secured €17M in a Series C round to fund clinical development of…